Printable page for all IPOs that have date "scheduled".
This week's IPOs have bold border. Close Window


Company: Anchor Bancorp Wisconsin Inc.
Symbol: ABCW
Price: $25.00-$27.00
Description: They are a savings and loan holding company headquartered in Madison, Wisconsin.
Trade Date: 10/22
Shares: 372 K
Type: IPO
Underwriter(s)   Co Manager(s)

Sandler O' Neill + Partners LP   Baird


Company: Boot Barn Holdings, Inc.
Symbol: BOOT
Price: $14.00-$16.00
Description: They are the largest and fastest-growing lifestyle retail chain devoted to western and work-related footwear, apparel and accessories in the U.S.
Trade Date: 10/30
Shares: 5 million
Type: IPO
Underwriter(s)   Co Manager(s)

J.P. Morgan, Piper Jaffray, Jefferies   Wells Fargo Securities, Baird


Company: Endostim, Inc.
Symbol: STIM
Price: $10.00-$12.00
Description: They are a medical device company focused on the development and commercialization of a novel neurostimulation system for the treatment of severe gastroesophageal reflux disease, or GERD.
Trade Date: 0/0
Shares: 3.2 million
Type: IPO
Underwriter(s)   Co Manager(s)

Wedbush PacGrow Life Sciences   Craig-Hallum Capital Group, Roth Capital Partners


Company: Fifth Street Asset Management
Symbol: FSAM
Price: $24.00-$26.00
Description: Fifth Street is a leading alternative asset manager with more than $5.6 billion of assets under management.
Trade Date: 10/22
Shares: 8 million
Type: IPO
Underwriter(s)   Co Manager(s)

Morgan Stanley, J.P. Morgan, Goldman Sachs, RBC Capital Markets, Credit Suisse   SMBC Nikko, Barclays, Deutsche Bank Securities, UBS Investment Bank, Janney Montgomery Scott, JMP Securities, Ladenburg Thalmann, KeyBanc Capital Markets, ING, Maxim Group LLC, MLV & Co., Sterne Agee, National Securities Corporation, Natixis


Company: GWG Holdings, Inc
Symbol: GWGH
Price: Priced at $12.50
Description: They are engaged in the emerging secondary market for life insurance. They acquire life insurance policies in the secondary market from policy owners desiring to sell their policies at a discount to the face value of the insurance benefit.
Trade Date: Opened 9/19
Shares: 800 K
Type: IPO
Underwriter(s)   Co Manager(s)

Newport Coast Securities, Axiom Capital Management, Newbridge Securities Corporation  


Company: Proteon Therapeutics, Inc.
Symbol: PRTO
Price: $12.00-$14.00
Description: They are a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease.
Trade Date: 10/22
Shares: 4.7 million
Type: IPO
Underwriter(s)   Co Manager(s)

Stifel, JMP Securities   Baird, Oppenheimer & Co.


Company: Shell Midstream Partners LP
Symbol: SHLX
Price: $19.00-$21.00
Description: They are a fee-based, growth-oriented master limited partnership recently formed by Shell to own, operate, develop and acquire pipelines and other midstream assets.
Trade Date: 10/29
Shares: 37.5 million
Type: IPO
Underwriter(s)   Co Manager(s)

Barclays, Citigroup, Morgan Stanley, UBS Investment Bank   Credit Suisse, Goldman Sachs & Co.,J.P. Morgan, Wells Fargo Securities, RBC Capital Markets, Credit Agricole CIB


Company: Sientra, Inc.
Symbol: SIEN
Price: $14.00-$16.00
Description: They are a medical aesthetics company committed to making a difference in patients' lives by enhancing their body image, growing their self-esteem and restoring their confidence.
Trade Date: 0/0
Shares: 5 million
Type: IPO
Underwriter(s)   Co Manager(s)

Piper Jaffray, Stifel   Leerink Partners, William Blair


Company: Viking Therapeutics, Inc.
Symbol: VKTX
Price: $10.00-$12.00
Description: They are a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders.
Trade Date: 0/0
Shares: 5 million
Type: IPO
Underwriter(s)   Co Manager(s)

Oppenheimer & Co., Roth Capital Partners   Craig-Hallum Capital Group, MLV & Co., Summer Street Research Partners


Company: Virobay, Inc.
Symbol: VBAY
Price: $12.00-$14.00
Description: They are a clinical-stage biopharmaceutical company utilizing our cysteine cathepsin platform for the development and commercialization of novel drugs.
Trade Date: 0/0
Shares: 3.8 million
Type: IPO
Underwriter(s)   Co Manager(s)

Piper Jaffray, JMP Securities,   Cantor Fitzgerald & Co., Summer Street Research Partners